Detection of K-ras point mutations in codons 12 and 13 in non-small cell lung cancers

Journal of the Formosan Medical Association

Volumn 95, Issue 10, 1996, Pages 741-745

  Hsu, Nan Yung ^a   Chen, Chih Yi ^a   Wu, Chii Huei ^a   Liu, Tse Fia ^a   Kwam, Po Cheung ^a   Hsu, Chung Ping ^a   Hsia, Jiun Yi ^a   Chang, Wu Tsung ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

codon 12; codon 13; K ras gene; mutation; non small cell lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CODON; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; TAIWAN;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CODON; FEMALE; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION;

EID: 0029852504     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Health and Vital Statistics. Department of Health, the Executive Yuan, Taiwan ROC 1972-1989.
2. Mitsudomi T, Viallet J, Mulshine JL, et al: Mutations of ras genes distinguish a subset of nonsmall-cell lung cancer cell lines from small-cell lung cancer cell lines, Oncogene 1991;6:1353-62.
3. Vries MV, Bogaard ME, van den Elst H, et ah A dot-blot screening procedure for mutated ras oncogenes using synthetic oligonucleotides. Gene 1986;50:313-20.
4. Slebos RJC, Habets GGM, Evers SG, et al: Allele-specific detection of K-ras oncogene expression in human non-small-cell lung carcinomas. Int J Cancer 1991;48:51-6.
5. Rosell R, Gomez-Codina J, Camps G, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with nora-small-cell lung cancer. New Engl J Med 1994;330:153-8.
6. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
7. Sugio K, Ishida T, Yokoyama H, et al: Rasgene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 1992;52;2903-6.
8. Rodenhuis S, Slebos RJC: Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 1992;52(suppl):2665-9.
9. Kobayashi T, Tsuda H, Noguchi M, et al: Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer 1990;66:289-94.
10. Slebos RJC, Kibbelaar RE, Dalesio O, et al: K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. New Engl J Med 1990;323:561-5.
11. Mitsudomi T, Steinberg SM, Oie HE, et al: Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res 1991;51:4999-5002.
12. Shen C, Chang JG, Lee LS, et al: Analysis of ras gene mutations in gastrointestinal cancer. J Formos Med Assoc 1991;90:1148-54.
13. Lee WJ, Lai MY, Wang TH, et al: Infrequent point mutation in codon 12 of the K- and Ha-ras oncogenes in gastric cancers. J Surg Assoc ROC 1994;27:2325-32.
14. Mountain CF: A new international staging system for lung cancer. Chest 1986;89:225-33.
15. Capon DJ, Seeburg PH, McGrath JP, et al: Activation of Ki-ras 2 gene in human colon and lung carcinomas by two different point mutations. Nature 1983;304:507-13.
16. Nagata Y, Abe M, Kobayashi K, et al: Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. Cancer Res 1990;50:480-2.
17. Lee J: Laboratory methods: alternative dideoxy sequencing of double-stranded DNA by cyclic reactions using Taq polymerase. DNA Cell Biol 1991;10:67-73.
18. Gonzalez-Cadavid NF, Zhou D, Battifora H, et al: Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinoma. Oncogene 1989;4:1137-40.
19. Farr GJ, Saiki RK, Erlich HA, et al: Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 1988;85:1629-33.
20. Ball ED, Mills LE, Neubauer A, et al: Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras genes using the polymerase chain reaction. Prog Clin Biol Res 1990;333:499-506.
21. Mills NE, Fishman CL, Rom WN, et al: Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 1995;55:1444-7.
22. Rodenhuis S, Van De Wetering ML, Mooi WJ, et al: Mutational activation of the K-ras oncogene: a possible pathogenetic factor in adenocarcinoma of the lung. New Engl J Med 1987;317:929-35.
23. Rodenhuis S, Slebos RJC, Boot AJM: Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the lung. Cancer Res 1988;48:5738-41.
24. Rosell R, Li S, Skacel Z, et al: Prognostic impact of mutated K-ras gene in surgically resected non-small cell rang cancer patients. Oncogene 1993;8:2407-20.
25. Belinsky SA, Devereux TR, Maronpot RR, et al: Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res 1989;49:5305-11.
26. Vachtenheim J, Horakova I, Novotna H, et al: Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Clin Cancer Res 1995;1:359-65.
27. Lung ML, Wong M, Lam WK, et al: Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 1992;70:760-3.
28. Sugio K, Kishimoto Y, Virmani AK, et al: K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 1994;54:5811-5.
29. Li ZH, Zheng J, Weiss LM, et al: c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 1994;144:303-9.
30. Kern JA, Slebos RJC, Top B, et al: C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J Clin Invest 1994;93:516.